{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:22:32Z","timestamp":1793197352842,"version":"4.5.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011828","name":"Guangxi Zhuang Autonomous Region Health and Family Planning Commission","doi-asserted-by":"publisher","award":["Z20200762"],"award-info":[{"award-number":["Z20200762"]}],"id":[{"id":"10.13039\/501100011828","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nucl. Med."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To calculate the physiological uptake of various tissues in patients with cancer using <jats:sup>18<\/jats:sup>F-AlF-NOTA-FAPI-04 (<jats:sup>18<\/jats:sup>F-FAPI-04) and <jats:sup>18<\/jats:sup>F-AlF-NOTA-FAPI-42 (<jats:sup>18<\/jats:sup>F-FAPI-42) PET\/CT and to compare the variation in standard uptake values between the two scans.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>This retrospective analysis included 40 patients with cancer who underwent <jats:sup>18<\/jats:sup>F-FAPI; the first 20 patients received <jats:sup>18<\/jats:sup>F-FAPI-04 PET\/CT and the remaining 20 patients received <jats:sup>18<\/jats:sup>F-FAPI-42 PET\/CT. A total of 49 normal tissues, including the brain (cerebrum\/cerebellum), parotid and submandibular glands, palatine tonsils, and thyroid, were identified on CT images. For these normal tissues, maximum standardized uptake value (SUVmax) and mean standardized uptake value (SUVmean) were calculated. We also compared the SUVmean of identical tissues to explore the difference in biodistribution between the two radiotracers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The accumulation of <jats:sup>18<\/jats:sup>F-FAPI-04 and <jats:sup>18<\/jats:sup>F-FAPI-42 showed an analogous pattern. High uptake of both radiotracers in the gallbladder, uterus, submandibular gland, and renal pelvis was demonstrated (range: SUVmax, 4.01\u20135.75; SUVmean, 2.92\u20134.22). Furthermore, the uptake of bony tissues was slightly higher in <jats:sup>18<\/jats:sup>F-FAPI-42 than in <jats:sup>18<\/jats:sup>F-FAPI-04 (range: SUVmean, 0.4 \u00b1 0.22\u20130.9 \u00b1 0.34 and 0.3 \u00b1 0.24\u20130.7 \u00b1 0.18, respectively, <jats:italic>p<\/jats:italic> &amp;lt; 0.05), while the uptake of some soft tissues was higher in <jats:sup>18<\/jats:sup>F-FAPI-04 than in <jats:sup>18<\/jats:sup>F-FAPI-42 (range: SUVmean, 0.9 \u00b1 0.24\u20131.5 \u00b1 0.35 and 0.9 \u00b1 0.26\u20131.2 \u00b1 0.37, respectively, <jats:italic>p<\/jats:italic> &amp;lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Both radioligands exhibited similar physiological uptake of normal tissues in patients with cancers. In addition, <jats:sup>18<\/jats:sup>F-FAPI-42 demonstrated higher uptake of bone tissues than <jats:sup>18<\/jats:sup>F-FAPI-04 while showing lower uptake of soft tissues than <jats:sup>18<\/jats:sup>F-FAPI-04.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnume.2022.927843","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T07:40:25Z","timestamp":1664437225000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of physiological uptake of normal tissues in patients with cancer using 18F-FAPI-04 and 18F-FAPI-42 PET\/CT"],"prefix":"10.3389","volume":"2","author":[{"given":"Xingyu","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2967\/jnumed.120.244806","article-title":"The latest developments in imaging of fibroblast activation protein","volume":"62","author":"Altmann","year":"2021","journal-title":"J Nucl Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41181-019-0069-0","article-title":"Targeting of activated fibroblasts for imaging and therapy","volume":"4","author":"Lindner","year":"2019","journal-title":"EJNMMI Radiopharm Chem"},{"key":"B3","first-page":"6406","article-title":"Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets","volume":"46","author":"Rettig","year":"1986","journal-title":"Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","article-title":"The role of fibroblast activation protein in health and malignancy","volume":"39","author":"Fitzgerald","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.3390\/cancers13194946","article-title":"FAP and FAPI-PET\/CT in malignant and non-malignant diseases: a perfect symbiosis?","volume":"13","author":"Dendl","year":"2021","journal-title":"Cancers"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein","volume":"59","author":"Lindner","year":"2018","journal-title":"J Nucl Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"68Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers","volume":"60","author":"Giesel","year":"2019","journal-title":"J Nucl Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1007\/s00259-021-05646-z","volume":"49","author":"Hu","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/RLU.0000000000003742","article-title":"Comparison of 18F-AlF-NOTA-FAPI and 18F-FDG imaging in a patient with gastric signet-ring cell carcinoma","volume":"46","author":"Guo","year":"2021","journal-title":"Clin Nucl Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1007\/s00259-020-04859-y","article-title":"Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers","volume":"47","author":"Syed","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B11","doi-asserted-by":"publisher","first-page":"9750080","DOI":"10.1155\/2021\/9750080","article-title":"FAPI-04 uptake in healthy tissues of cancer patients in 68Ga-FAPI-04 PET\/CT imaging","volume":"2021","author":"G\u00fcndogan","year":"2021","journal-title":"Contrast Media Mol Imaging"},{"key":"B12","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.apsb.2021.09.032","article-title":"Preclinical evaluation and pilot clinical study of (18F)AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts","volume":"12","author":"Hu","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B13","doi-asserted-by":"publisher","first-page":"649148","DOI":"10.3389\/fonc.2021.649148","article-title":"FAPI-04 PET\/CT Using (18F)AlF labeling strategy: automatic synthesis, quality control, and in vivo assessment in patient","volume":"11","author":"Jiang","year":"2021","journal-title":"Front Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1007\/s00259-021-05470-5","article-title":"Clinical translational evaluation of Al18F-NOTA-FAPI for fibroblast activation protein-targeted tumour imaging","volume":"48","author":"Wang","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B15","doi-asserted-by":"publisher","first-page":"651005","DOI":"10.3389\/fonc.2021.651005","article-title":"Dynamic PET\/CT imaging of 68Ga-FAPI-04 in Chinese subjects","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2967\/jnumed.119.236786","article-title":"Radiation dosimetry and biodistribution of 68Ga-FAPI-46 PET imaging in cancer patients","volume":"61","author":"Meyer","year":"2020","journal-title":"J Nucl Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1007\/s00259-021-05378-0","article-title":"68Ga-FAPI-PET\/CT in patients with various gynecological malignancies","volume":"48","author":"Dendl","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"688","DOI":"10.2967\/jnumed.115.153767","article-title":"Semiquantitative analysis of the biodistribution of the combined 18F-NaF and 18F-FDG administration for PET\/CT imaging","volume":"56","author":"Minamimoto","year":"2015","journal-title":"J Nucl Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A tumor-imaging method targeting cancer-associated fibroblasts","volume":"59","author":"Loktev","year":"2018","journal-title":"J Nucl Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11307-006-0075-y","article-title":"Standardized uptake value atlas: characterization of physiological 2-deoxy-2-[18F]fluoro-D-glucose uptake in normal tissues","volume":"9","author":"Wang","year":"2007","journal-title":"Mol Imaging Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11307-021-01679-w","article-title":"Clinical utility of F-18 labeled fibroblast activation protein inhibitor (FAPI) for primary staging in lung adenocarcinoma: a prospective study","volume":"24","author":"Li","year":"2022","journal-title":"Mol Imaging Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of (68Ga)Ga-DOTA-FAPI-04 and (18F) FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer","volume":"47","author":"Chen","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1007\/s00259-021-05307-1","article-title":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET\/CT in cancer patients","volume":"48","author":"Giesel","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."}],"container-title":["Frontiers in Nuclear Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnume.2022.927843\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T07:40:30Z","timestamp":1664437230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnume.2022.927843\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":24,"alternative-id":["10.3389\/fnume.2022.927843"],"URL":"https:\/\/doi.org\/10.3389\/fnume.2022.927843","relation":{},"ISSN":["2673-8880"],"issn-type":[{"value":"2673-8880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"article-number":"927843"}}